glutamine has been researched along with Familial Nonmedullary Thyroid Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, C; Feng, C; Guan, H; Wang, H; Wang, R; Yu, X; Yu, Y | 1 |
| Ciarrocchi, A; Gandolfi, G; Piana, S; Sancisi, V | 1 |
| Jung, WH; Kim, HM; Koo, JS; Sun, WY | 1 |
1 review(s) available for glutamine and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinoma.
Topics: Amino Acid Substitution; Animals; Carcinoma; Carcinoma, Papillary; Glutamine; Humans; Prognosis; Proto-Oncogene Proteins B-raf; Thyroid Cancer, Papillary; Thyroid Neoplasms; Valine | 2015 |
2 other study(ies) available for glutamine and Familial Nonmedullary Thyroid Cancer
| Article | Year |
|---|---|
Targeting glutaminase-mediated glutamine dependence in papillary thyroid cancer.
Topics: Adult; Aged; Apoptosis; Autophagy; Biomarkers; Cell Line, Tumor; Cell Movement; Cell Respiration; Female; Glutaminase; Glutamine; Humans; Male; Mechanistic Target of Rapamycin Complex 1; Middle Aged; Mitochondria; Neoplasm Staging; Signal Transduction; Thyroid Cancer, Papillary; Tumor Burden | 2018 |
Expression of serine/glycine metabolism-related proteins is different according to the thyroid cancer subtype.
Topics: Carcinoma; Carcinoma, Papillary; Disease-Free Survival; Glutamine; Glycine; Humans; Mutation; Neoplasm Proteins; Prognosis; Serine; Thyroid Cancer, Papillary; Thyroid Neoplasms | 2016 |